Urology treats urinary tract diseases in all genders and male reproductive issues, covering the kidneys, bladder, prostate, urethra, from infections to complex cancers.
Send us all your questions or requests, and our expert team will assist you.
The clinical presentation of hypospadias results directly from an interruption in the masculinization program of the genital tubercle. The primary symptom is the ectopic location of the urethral meatus. This displacement can alter the urinary stream, causing it to spray or deflect downwards, which may necessitate sitting to void. Beyond the urinary mechanics, the condition is often associated with chordee, a ventral curvature of the penis that becomes most apparent during erection. This curvature is caused by the tethering effect of the dysplastic urethral plate, the fibrosis of the corpus spongiosum, or the disproportionate growth of the dorsal versus ventral corporal bodies.
The “hooded” prepuce is a pathognomonic sign, where the foreskin fails to fuse ventrally, leaving the glans exposed on the underside while accumulating excess skin dorsally. This aberrant skin distribution is not merely cosmetic; the dorsal hood is a critical reservoir of vascularized tissue often utilized in surgical reconstruction. In severe proximal hypospadias, the scrotum may be bifid (split) or transposed above the penis (penoscrotal transposition), reflecting a more profound disruption of the urogenital swelling migration.
From a physiological standpoint, severe hypospadias can be a marker of a Disorder of Sex Development (DSD). The coexistence of cryptorchidism (undescended testicle) with hypospadias significantly increases the likelihood of an underlying genetic or endocrine disorder, such as mixed gonadal dysgenesis or partial androgen insensitivity syndrome. This association necessitates a comprehensive systemic evaluation to rule out life-threatening conditions like congenital adrenal hyperplasia in newborns.
The risk factors for hypospadias are increasingly linked to the metabolic health of the placental fetal unit. The placenta is the primary source of human chorionic gonadotropin (hCG) in early pregnancy, which stimulates the fetal Leydig cells to produce the testosterone necessary for penile growth. Placental insufficiency, often associated with preeclampsia, intrauterine growth restriction (IUGR), or maternal hypertension, leads to reduced hCG levels and a subsequent “masculinization window” failure.
Low birth weight is one of the most consistent risk factors for hypospadias. This correlation underscores the importance of adequate fetal nutrition and placental function in urogenital development. Infants born small for gestational age have a significantly higher incidence of the defect, suggesting that the metabolic stress of growth restriction diverts energy away from non-vital organogenesis, such as genital differentiation. Maternal obesity and gestational diabetes are also emerging risk factors, potentially due to the estrogenic environment created by adipose tissue or the disruption of insulin signaling pathways involved in cell growth.
The “estrogen hypothesis” posits that increasing exposure to environmental endocrine-disrupting chemicals (EDCs) is driving the rising incidence of hypospadias globally. EDCs such as phthalates (found in plastics), bisphenol A (BPA), and agricultural pesticides can cross the placental barrier. These chemicals act as anti-androgens or estrogen mimics, interfering with the androgen receptor signaling in the developing male fetus.
Epigenetic modifications are a key mechanism of this environmental toxicity. Exposure to EDCs can induce DNA methylation or histone modification in the genes regulating genital development, such as HOXA and MAFB. These epigenetic changes can silence the expression of genes required for urethral fusion without altering the underlying DNA sequence. This transgenerational epigenetic inheritance suggests that environmental exposures in one generation could affect the reproductive health of subsequent generations.
While most cases are sporadic, a genetic component is evident in familial clusters. The risk of hypospadias increases significantly if a father or sibling is affected. Genome-wide association studies have identified susceptibility loci related to thin-catenin beta-catenin in the DGKK gene, which are involved in both the outgrowth and patterning of the genital tubercle.
Mutations in the Androgen Receptor (AR) or 5α-reductase type 2 (SRD5A2) genes are found in a subset of patients, particularly those with severe forms of the disease. However, in many cases, the defect is polygenic, involving complex interactions among multiple minor gene variants and environmental triggers. Molecular signaling defects in the Bone Morphogenetic Protein (BMP) and Fibroblast Growth Factor (FGF) pathways can also lead to the failure of the urethral plate to canalize, arresting development at a specific stage.
Maternal factors such as advanced age and the use of Assisted Reproductive Technologies (ART), like in vitro fertilization (IVF) and intracytoplasmic sperm injection (ICSI), are associated with an elevated risk of hypospadias. This association may be due to the underlying parental subfertility, the hormonal manipulations required for ovulation induction, or the epigenetic reprogramming that occurs during gamete manipulation. Additionally, maternal intake of certain medications, such as valproic acid or progestins during the first trimester, has been linked to an interference with fetal androgen synthesis.
Physiological Stages of Condition
Systemic Risk Factors and Metabolic Comorbidities
Comparative Clinical Objectives
Send us all your questions or requests, and our expert team will assist you.
The link between In Vitro Fertilization (IVF) and hypospadias is multifactorial. It is thought to be related to the higher rates of low birth weight and prematurity in IVF pregnancies, which are known risk factors. Additionally, the underlying fertility issues of the parents may carry genetic traits that predispose the offspring to genital anomalies. There is also a hypothesis that the hormonal supplementation (progesterone) used to support IVF pregnancies might interfere with fetal androgen signaling.
Chordee is a downward (ventral) curvature of the penis, often associated with hypospadias. It is caused by a difference in the length or elasticity of the tissues on the underside of the penis compared to the top. This can be due to skin tethering, fibrosis of the tissue surrounding the urethra (corpus spongiosum), or a disproportion between the corporal bodies. Correcting the chordee to ensure a straight erection is a critical part of the surgical repair.
While no specific food causes hypospadias, maternal diet plays a role in overall placental health and fetal development. Diets lacking in essential nutrients or high in processed foods may contribute to metabolic conditions like gestational diabetes or obesity, which are risk factors. Furthermore, consuming food contaminated with pesticides or endocrine-disrupting chemicals (often found in non-organic produce or plastic packaging) may increase the risk by interfering with hormonal signaling.
In the vast majority of cases, hypospadias is an isolated anomaly in an otherwise healthy male. However, severe proximal hypospadias, especially when accompanied by one or both undescended testicles, can be a clinical indicator of a Disorder of Sex Development (DSD), formerly referred to as intersex conditions. In these complex presentations, genetic and hormonal testing is mandatory to determine the chromosomal sex and rule out conditions such as congenital adrenal hyperplasia.
The curvature associated with hypospadias typically does not worsen on its own in childhood. However, it becomes more apparent during erections. If left uncorrected, the curvature can become a significant functional issue during puberty and adulthood, potentially making sexual intercourse difficult or painful. During the rapid growth phase of puberty, if the scarred urethra does not grow as fast as the rest of the penis, a previously corrected curvature could theoretically recur or become noticeable.
Leave your phone number and our medical team will call you back to discuss your healthcare needs and answer all your questions.
Your Comparison List (you must select at least 2 packages)
